The trademark XELOMA was filed by Tetra Pharm Technologies, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on November 7, 2021, and received one opposition filed on February 2, 2022 by F. Hoffmann-La Roche AG on Likelihood of confusion. the opponent was represented by GEVERS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued February 2, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
The Opposition with reference B 003163376 was refused according to Article 8(1)(b) EUTMR with decision issued on February 4, 2023 by the EUIPO.